2Scorza T,Souza S,Laloup M,et al.A GRA1 DNA vaccine primes cytolytic CD8^+ T cells to control acute Toxoplasma gondii infection[J].Infect Immun,2003,71(1):309-316.
3Suzuki Y,Remington JS.Dual regulation of resistance against Toxoplasma gondii infection by lyt^2+,Iyt^1+ and L3T^4+ T cells in mice[J].Immun,1988,140(11):3943-3946.
4Casciotti L,Ely Kh,Williams ME,et al.CD8^+T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4^+ T cells[J].Infect Immun,2002,70(2):434-443.
5Sonja Lütjen,Sabine Soltek,Simona Virna,et al.Regulation of Toxoplasma gondii specific CD8^+T-cell responses by CD4^+T cells[J].Infect Immun,2006,74(10):5790-5801.
6Abou-Bacar A,Pfaff AW,Georges S,et al.Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection[J].Infect Immun,2004,72(3):1397-1401.
7Barbara A,Butcher,Eric Y.Mechanism of entry determines the ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production[J].Infect Immun,2002,70(9):5216-5224.
8Fausto G,Araujo,Teri Slifer.Different strains of Toxoplasma gondii induce different cytokine responses in CBA/Ca Mice[J].Infect Immun,2003,71(7):4171-4174.
10Beaman Mh,Remington JS.Enhancement of intracellular replication of by IL-6 interaction with IFN-gamma and IFN-alpha[J].Immunol,2000,153(10):4583-4587.
8Wegmann TG. Is successful pregnancy a Th2 phenomenon? Immun Today, 1993,14 : 353-356.
9Shirihata T, Muroya N, Ohta C. Correlation between increased susceptibity to primary toxoplasmosis gondii infection and depressed production of gamma interfon in pregnant mice. Microbiol Immunol, 1992,36 : 81-91.
10Halonen SK, Weiss LM. Investigation into the mechanism of gamma interferon-mediated inhibition of toxoplasma gondii in murine astrocytes. Infect Immun,2000.68: 3426-3430.
3Pelloux H, Weiss J, Simon J, et al. A new set of primers for the detection of Toxoplasma gondii in amniotic fluid using polymerase chain reaction [ J]. FEMS Microbiol Lett, 1996, 138 ( 1 ) : 11-15.
4Stahl W, Matsubayashi H, Akao S. Modification of subclinical toxoplasmosis in mice by cortisone, 6-mercaptopurine and splenectomy [J]. Am J Trop Med Hyg, 1966, 15(6) : 869-874.
5Kang KN, Choi IU, Shin DW, et al. Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamethasone [J]. Korean J Parasitol, 2006, 44(3) : 209-219.
6Degerli K, Kilimciogllu AA, Kurt O, et al. Efficacy of zaithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey [J]. Acta Trop, 2003, 88(1 ): 45-50.
7Suzuki Y, Orellana MA, Schreiber RD, et al. Remington Interferongamma : the major mediator of resistance against Toxoplasma gondii [ J]. Science, 1988, 240(4851) : 516-518.
8Bossi P, Caumes E, Paris L, et al. Toxoplasma gondii-associated Guillain-Barr6 syndrome in an Immunocompetent patient [ J ]. J Clin Microbiol, 1998, 36(12) :3724-3725.
9Torok ME. Human immunodeficiency virus associated central nervous system infections [ J ]. Pract Neurol, 2005, 5 (6) : 334-349.
10Yazar S, Yaman O, Eser B, et al. Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia [ J]. Med Microbial, 2004, 53 (Pt 12) : 1183-1186.
